Navigation Links
Kosan Announces Third Quarter 2007 Financial Results
Date:11/8/2007

e timing thereof) and potential safety, efficacy, commercialization and other characteristics of Kosan's product candidates, including tanespimycin, alvespimycin and KOS-1584. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. There are a number of important factors that could cause the results of Kosan to differ materially from those indicated by these forward- looking statements, including, among others, risks related to Kosan's expectation that additional financing will be required, Kosan's past dependence on its collaboration with Roche for development of its epothilone product candidates and current dependence on Pfizer for development of KOS- 2187, Kosan's ability to enter into new partnering arrangements and the highly uncertain nature of the progress and results of Kosan's testing of its product candidates, including the risk that studies may not demonstrate safety and efficacy sufficient to initiate additional clinical trials, continue clinical development, obtain the requisite regulatory approvals or result in a marketable product, competition and other risks detailed from time to time in Kosan's SEC reports, including its Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 and other periodic filings with the SEC. Kosan does not undertake any obligation to update forward-looking statements.

Herceptin(R) (trastuzumab) is a registered trademark of Genentech, Inc.

Selected Financial Information

Condensed Statements of Operations

(in thousands, except per share amounts)

(unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006

Total revenues $1,947 $2,169 $17,071 $7,796

Operating expenses:'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference
3. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
4. Kosan Biosciences to Host Research & Development Day on October 31, 2007
5. Kosan to Reacquire Epothilone Program From Roche
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... rely on sophisticated equipment, trained personnel, and detection ... against terrorist attacks. A revolutionary new electronic chip ... their job much easier. , The groundbreaking nanotechnology-inspired ... Aviv University ,s School of Chemistry and Center ... Herzliya company Tracense, picks up the scent of ...
(Date:7/24/2014)... Yan, Distinguished Professor of Engineering at the University ... to solve problems in energy engineering, environmental sustainability ... on zeolites, porous rock with a well-defined, crystalline ... is so precisely decided that zeolites can separate ... of an angstrom (one-tenth of a nanometer), making ...
(Date:7/24/2014)... , July 24, 2014 Research ... "Global Genomics and Proteomics Analytical Instruments Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Genomics is the study ... the study of the structure and functions of proteomes ... bioinformatics tools and technology. Genomics involves the mapping of ...
(Date:7/24/2014)... , July 24, 2014  CorMedix Inc. (NYSE ... and commercializing therapeutic products for the prevention and ... receipt of notice on July 18, 2014 from ... has accepted the CorMedix plan to regain compliance ... a result, the NYSE-MKT is continuing the Company,s ...
Breaking Biology Technology:Nano-sized chip 'sniffs out' explosives far better than trained dogs 2University of Delaware researcher describes new approach for creating organic zeolites 2Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3
... - At least six Wisconsin biotech companies will ... event that may be another signal of the rising ... ,The Wisconsin companies will travel to Minneapolis for the ... the Biotechnology Industry Organization . Companies will present ...
... Richmond, Wis. - Wisconsin Gov. Jim Doyle said he ... for agricultural and forestry bio-industry development. The funds are part ... ,"A growing bio-economy will help rural communities and local farmers ... markets for their products," Doyle said. "And investing in our ...
... Wis. - During a week in which President Bush ... Court, it would have been easy to overlook the storm ... Wisconsin Supreme Court. If you're a business owner worried about ... to recent decisions by Wisconsin's highest court as you do ...
Cached Biology Technology:Six Wisconsin firms to present at BIO Mid-America VentureForum 2Six Wisconsin firms to present at BIO Mid-America VentureForum 3Business liability law complaints grow with state Supreme Court decisions 2Business liability law complaints grow with state Supreme Court decisions 3
(Date:7/25/2014)... from 25 countries and 35 states will attend ... Genetics Society of America (GSA) next week at ... will feature close to 500 presentations (including 70 ... gene expression and regulation, functional genomics, chemical biology ... a variety of diseases. , Of special ...
(Date:7/25/2014)... central nervous system disease that is caused by ... the embryonic phase. Many patients have varying degrees ... retardation. Such problems decrease the patients, functional independence ... Physical Medicine and Rehabilitation Education and Research Hospital, ... SB, using the Pediatric Evaluation of Disability Inventory ...
(Date:7/25/2014)... first time, Spanish researchers have detected an unknown interaction ... cells are introduced into a droplet of salt water ... chloride crystallisation to create biomineralogical biosaline 3D morphologically complex ... material, bacteria are revived. The discovery was made by ... cover of the Astrobiology journal and may ...
Breaking Biology News(10 mins):Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2Bacteria manipulate salt to build shelters to hibernate 2
... Biogeoscientists show evidence of 90 billion tons of microbial ... biosphere, in a research article published online by ... about one-tenth of the amount of carbon stored globally ... Lipp of the Center for Marine Environmental Sciences (MARUM) ...
... Many cell transplants involve the use of stem cells ... raises the major concern of the potential for acute ... is elicited by the grafted cells against the recipient, ... Presently, there are no definitive markers for predicting the ...
... a time has earned acceptance in biology laboratories over the ... a tool to treat a variety of diseases if it ... discovered that antibiotics known as fluoroquinolones can make RNA interference ... The results will be published online this week in the ...
Cached Biology News:Nature publishes new evidence about the deep biosphere written by biogeoscientists 2Nature publishes new evidence about the deep biosphere written by biogeoscientists 3Predicting acute GVHD by gene expression could improve liver stem cell transplant outcomes 2Class of antibiotics can enhance gene-silencing tool 2
... is designed for paramagnetic bead precipitation from ... has a plastic base in a standard ... use of 96 extremely strong permanent magnetic ... With this magnetic stand, paramagnetic beads in ...
... aquaticus expressed in E. coli; 5 units/L; ... units enzyme/tube and Buffer I AmpliTaq DNA ... enzyme as AmpliTaq DNA Polymerase but is ... to ensure that contaminating bacterial DNA sequences ...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
... is a versatile and easy-to use enzyme, ... GCpro Taq DNA Polymerase is prepared from ... containing the DNA polymerase I gene from ... processive 5'-3' DNA polymerase activity. Its inherent ...
Biology Products: